Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- Conditions
- Idiopathic Pulmonary FibrosisInterstitial Lung Disease
- Interventions
- Device: Treprostinil Ultrasonic Nebulizer
- Registration Number
- NCT04905693
- Lead Sponsor
- United Therapeutics
- Brief Summary
Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.
- Detailed Description
Study RIN-PF-302 is a Phase 3, multicenter, open-label extension (OLE) study for eligible subjects who completed Study RIN-PF-301 or Study RIN-PF-303 to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis (IPF). Following OLE entry, subjects will return at Week 4, Week 12, and every 12 weeks thereafter for up to 6 years or until the subject prematurely discontinues study treatment due an adverse event (AE)/serious adverse event (SAE) or other reason, inhaled treprostinil becomes commercially available for IPF, or the study is discontinued by the Sponsor (whichever is sooner).
Efficacy assessments will include spirometry (forced expiratory volume in 1 second \[FEV1\] and forced vital capacity \[FVC\]), time to clinical worsening, time to first acute exacerbation of IPF, overall survival, King's Brief Interstitial Lung Disease (K-BILD) Questionnaire, plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration, supplemental oxygen use, and diffusion capacity of lungs for carbon monoxide (DLCO). Safety assessments will include monitoring for the development of AEs/SAEs, vital signs, clinical laboratory parameters, and electrocardiogram (ECG) parameters. In addition, up to 24 eligible subjects may participate in a PK substudy to evaluate the systemic exposure of treprostinil after inhaled administration.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 792
- Subject gives voluntary informed consent to participate in the study.
- The subject participated in Study RIN-PF-301 or Study RIN-PF-303 and remained on study drug and completed all scheduled study visits or was enrolled in Study RIN-PF-301 or Study RIN-PF-303 at the time that the study or study subject was discontinued by the Sponsor.
- Women of childbearing potential must be non-pregnant (as confirmed by a urine pregnancy test at OLE Entry Visit and Baseline) and non-lactating, and will abstain from intercourse (when it is in line with their preferred and usual lifestyle) or use 2 medically acceptable, highly effective forms of contraception for the duration of the study, and at least 30 days after discontinuing study drug.
- Males with a partner of childbearing potential must use a condom for the duration of treatment and for at least 48 hours after discontinuing study drug.
- In the opinion of the Investigator, the subject is able to communicate effectively with study personnel, and is considered reliable, willing, and likely to be cooperative with protocol requirements, including attending all study visits.
- Subject is pregnant or lactating.
- In the opinion of the Investigator, enrollment in Study RIN-PF-302 would represent a risk to the subject's overall health.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Inhaled Treprostinil Inhaled Treprostinil Treprostinil inhalation solution (0.6 mg/mL) delivered via an ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath. Inhaled QID and titrated to a target of 15 breaths QID or until the subject reaches their maximum clinically tolerated dose. Inhaled Treprostinil Treprostinil Ultrasonic Nebulizer Treprostinil inhalation solution (0.6 mg/mL) delivered via an ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath. Inhaled QID and titrated to a target of 15 breaths QID or until the subject reaches their maximum clinically tolerated dose.
- Primary Outcome Measures
Name Time Method Long-term safety and tolerability of inhaled treprostinil in subjects with IPF Baseline to 6 years Incidence of AEs and SAEs, incidence of abnormal clinical laboratory parameters, abnormal vital signs, and abnormal 12-lead ECGs
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (168)
Community Health Network
馃嚭馃嚫Indianapolis, Indiana, United States
PulmonIx, LLC
馃嚭馃嚫Greensboro, North Carolina, United States
H么pital Bretonneau
馃嚝馃嚪Tours, Indre-et-Loire, France
CHU Amiens-Picardie
馃嚝馃嚪Amiens, France
AP-HP - Hopital Avicenne
馃嚝馃嚪Bobigny, France
Hospices Civils De Lyon - Universit茅 Hospital of Lyon
馃嚝馃嚪Bron, France
AP-HP - H么pital Europ茅en Georges Pompidou
馃嚝馃嚪Paris, France
H么ptial Bichat
馃嚝馃嚪Paris, France
Centre Hospitalier Universitaire De Reims - H么pital Maison Blanche
馃嚝馃嚪Reims, France
H么pital Pontchaillou
馃嚝馃嚪Rennes, France
Sheba Medical Center - PPDS
馃嚠馃嚤Ramat Gan, Tel-Aviv, Israel
Lady Davis Carmel Medical Center
馃嚠馃嚤Haifa, Israel
Meir Medical Center
馃嚠馃嚤Kfar Saba, Israel
Rabin Medical Center - PPDS
馃嚠馃嚤Petah Tiqva, Israel
Tel Aviv Sourasky Medical Center - PPDS
馃嚠馃嚤Tel Aviv, Israel
Fondazione Policlinico Universitario A Gemelli-Rome
馃嚠馃嚬Roma, Lazio, Italy
Gruppo MultiMedica SpA - Ospedale San Giuseppe
馃嚠馃嚬Milan, Lombardia, Italy
Azienda ospedaliero-universitaria Senese
馃嚠馃嚬Siena, Toscana, Italy
Azienda Ospedaliero Universitaria delle Marche
馃嚠馃嚬Ancona, Italy
Presidio Ospedaliero GB Morgagni L Pierantoni
馃嚠馃嚬Forl矛, Italy
Hospital General Universitario Gregorio Mara帽on
馃嚜馃嚫Madrid, Spain
Hospital Clinico San Carlos
馃嚜馃嚫Madrid, Spain
Hospital Clinico Universitario Virgen de La Arrixaca
馃嚜馃嚫Murcia, Spain
Hospital Universitario Marques de Valdecilla
馃嚜馃嚫Santander, Spain
Kaohsiung Medical University - Chung-Ho Memorial Hospital
馃嚚馃嚦Kaohsiung, Taiwan
E-DA hospital
馃嚚馃嚦Kaohsiung, Taiwan
CHU de Li猫ge
馃嚙馃嚜Li猫ge, Belgium
Emory University
馃嚭馃嚫Atlanta, Georgia, United States
The University of Alabama at Birmingham
馃嚭馃嚫Birmingham, Alabama, United States
Clinical Trials Center of Middle Tennessee
馃嚭馃嚫Franklin, Arizona, United States
Banner University Medical Center-Phoenix
馃嚭馃嚫Phoenix, Arizona, United States
St. Joseph's Hospital and Medical Center - Norton Thoracic Institute
馃嚭馃嚫Phoenix, Arizona, United States
University of Arizona
馃嚭馃嚫Tucson, Arizona, United States
David Geffen School of Medicine at UCLA
馃嚭馃嚫Los Angeles, California, United States
NewportNativeMD, Inc
馃嚭馃嚫Newport Beach, California, United States
Palmtree Clinical Research, Inc.
馃嚭馃嚫Palm Springs, California, United States
UC Davis Health Medical Center
馃嚭馃嚫Sacramento, California, United States
Stanford University School of Medicine
馃嚭馃嚫Stanford, California, United States
National Jewish Health
馃嚭馃嚫Denver, Colorado, United States
University of Florida Health at Shands
馃嚭馃嚫Gainesville, Florida, United States
Ascension St. Vincent's
馃嚭馃嚫Jacksonville, Florida, United States
University of Florida
馃嚭馃嚫Jacksonville, Florida, United States
Mayo Clinic Florida
馃嚭馃嚫Jacksonville, Florida, United States
Pulmonary Disease Specialists, PA d/b/a PDS Research
馃嚭馃嚫Kissimmee, Florida, United States
Central Florida Pulmonary Group, PA
馃嚭馃嚫Orlando, Florida, United States
Coastal Pulmonary & Critical Care PLC
馃嚭馃嚫Saint Petersburg, Florida, United States
University of South Florida Health
馃嚭馃嚫Tampa, Florida, United States
Cleveland Clinic Florida
馃嚭馃嚫Weston, Florida, United States
Piedmont Healthcare Atlanta
馃嚭馃嚫Atlanta, Georgia, United States
Northwestern Memorial Hospital
馃嚭馃嚫Chicago, Illinois, United States
Loyola University Medical Center
馃嚭馃嚫Maywood, Illinois, United States
University of Kansas Medical Center
馃嚭馃嚫Kansas City, Kansas, United States
Norton Pulmonary Specialists
馃嚭馃嚫Louisville, Kentucky, United States
University of Louisville Healthcare Outpatient Center
馃嚭馃嚫Louisville, Kentucky, United States
Tulane University Medical Center
馃嚭馃嚫New Orleans, Louisiana, United States
LSU Health Science Center Shreveport
馃嚭馃嚫Shreveport, Louisiana, United States
Johns Hopkins Asthma and Allergy Center
馃嚭馃嚫Baltimore, Maryland, United States
Adventist Healthcare White Oak Medical Center
馃嚭馃嚫Silver Spring, Maryland, United States
Tufts Medical Center
馃嚭馃嚫Boston, Massachusetts, United States
Brigham and Women's Hospital
馃嚭馃嚫Boston, Massachusetts, United States
University of Michigan Int Med Pulmonary and critical care
馃嚭馃嚫Ann Arbor, Michigan, United States
Henry Ford Hospital
馃嚭馃嚫Detroit, Michigan, United States
Corewell Health William Beaumont Hospital
馃嚭馃嚫Royal Oak, Michigan, United States
University of Minnesota
馃嚭馃嚫Minneapolis, Minnesota, United States
Mayo Clinic, Division of Pulmonary and Critical Care Medicine
馃嚭馃嚫Rochester, Minnesota, United States
University Mississippi Medical Center
馃嚭馃嚫Jackson, Mississippi, United States
The Lung Research Center, LLC
馃嚭馃嚫Chesterfield, Missouri, United States
Washington University School of Medicine
馃嚭馃嚫Saint Louis, Missouri, United States
Creighton University Clinical Research Office
馃嚭馃嚫Omaha, Nebraska, United States
University of New Mexico Health Sciences Center
馃嚭馃嚫Albuquerque, New Mexico, United States
Montefiore Medical Center
馃嚭馃嚫Bronx, New York, United States
Northwell Health
馃嚭馃嚫New Hyde Park, New York, United States
University of Rochester Medical Center
馃嚭馃嚫Rochester, New York, United States
East Carolina University
馃嚭馃嚫Greenville, North Carolina, United States
Southeastern Research Center
馃嚭馃嚫Winston-Salem, North Carolina, United States
University of Cincinnati Medical Center
馃嚭馃嚫Cincinnati, Ohio, United States
Cleveland Clinic
馃嚭馃嚫Cleveland, Ohio, United States
The Ohio State University Wexner Medical Center
馃嚭馃嚫Columbus, Ohio, United States
University of Oklahoma Health Sciences Center
馃嚭馃嚫Oklahoma City, Oklahoma, United States
The Oregon Clinic
馃嚭馃嚫Portland, Oregon, United States
Penn State Milton S.Hershey Medical Center
馃嚭馃嚫Hershey, Pennsylvania, United States
Hospital of the University of Pennsylvania
馃嚭馃嚫Philadelphia, Pennsylvania, United States
Thomas Jefferson,Hospital University
馃嚭馃嚫Philadelphia, Pennsylvania, United States
Temple University Hospital
馃嚭馃嚫Philadelphia, Pennsylvania, United States
Medical University of South Carolina
馃嚭馃嚫Charleston, South Carolina, United States
Prisma Health Midlands
馃嚭馃嚫Columbia, South Carolina, United States
Clinical Research of Rock Hill
馃嚭馃嚫Rock Hill, South Carolina, United States
StatCare Pulmonary Consultants, PLLC
馃嚭馃嚫Knoxville, Tennessee, United States
Vanderbilt University Medical Center
馃嚭馃嚫Nashville, Tennessee, United States
Baylor University Medical Center
馃嚭馃嚫Dallas, Texas, United States
University of Texas Southwestern Medical Center
馃嚭馃嚫Dallas, Texas, United States
Baylor College of Medicine
馃嚭馃嚫Houston, Texas, United States
The University of Texas Health Science Center at Houston
馃嚭馃嚫Houston, Texas, United States
A & A Research Consultants, LLC
馃嚭馃嚫McAllen, Texas, United States
Metroplex Pulmonary and Sleep Center PA
馃嚭馃嚫McKinney, Texas, United States
Renovatio Clinical
馃嚭馃嚫The Woodlands, Texas, United States
Intermountain Healthcare
馃嚭馃嚫Murray, Utah, United States
University of Utah Health
馃嚭馃嚫Salt Lake City, Utah, United States
University of Virginia Health Systems
馃嚭馃嚫Charlottesville, Virginia, United States
Inova Fairfax Hospital
馃嚭馃嚫Falls Church, Virginia, United States
Pulmonary Associates of Richmond, Inc.
馃嚭馃嚫Richmond, Virginia, United States
University Hospital and UW Health Clinics
馃嚭馃嚫Madison, Wisconsin, United States
Medical College of Wisconsin
馃嚭馃嚫Milwaukee, Wisconsin, United States
CINME S.A. - Centro de Investigaciones Metab贸licas
馃嚘馃嚪Ciudad Aut贸noma de Buenos Aires, Buenos Aires, Argentina
Instituto Ave Pulmo - Fundaci贸n enfisema
馃嚘馃嚪Mar del Plata, Buenos Aires, Argentina
Sanatorio Allende Cerro
馃嚘馃嚪C贸rdoba, Provincia De C贸rdoba, Argentina
Instituto Medico R铆o Cuarto
馃嚘馃嚪Rio Cuarto, Provincia De C贸rdoba, Argentina
Centro M茅dico INSARES
馃嚘馃嚪Mendoza, Provincia De Mendoza, Argentina
Centro Integral de Medicina Respiratoria (CIMER)
馃嚘馃嚪San Miguel de Tucum谩n, Tucum谩n, Argentina
Investigaciones en Patolog铆as Respiratorias
馃嚘馃嚪San Miguel de Tucum谩n, Tucum谩n, Argentina
Centro M茅dico Dra. De Salvo
馃嚘馃嚪Ciudad Aut贸noma de Buenos Aires, Argentina
Royal Prince Alfred Hospital
馃嚘馃嚭Camperdown, New South Wales, Australia
Macquarie University
馃嚘馃嚭Macquarie Park, New South Wales, Australia
Westmead Hospital
馃嚘馃嚭Westmead, New South Wales, Australia
Lung Research Qld
馃嚘馃嚭Chermside, Queensland, Australia
The Prince Charles Hospital
馃嚘馃嚭Chermside, Queensland, Australia
Mater Misericordiae Ltd
馃嚘馃嚭South Brisbane, Queensland, Australia
Alfred Health
馃嚘馃嚭Melbourne, Victoria, Australia
Ziekenhuis Aan de Stroom
馃嚙馃嚜Antwerpen, Belgium
Cliniques Universitaires Saint-Luc
馃嚙馃嚜Brussels, Belgium
UZ Leuven
馃嚙馃嚜Leuven, Belgium
CHR de la Citadelle
馃嚙馃嚜Li猫ge, Belgium
St. Joseph's Healthcare Hamilton
馃嚚馃嚘Hamilton, Ontario, Canada
Centre d'investigation Clinique Mauricie
馃嚚馃嚘Trois-Rivi猫res, Quebec, Canada
Institut Universitaire de Cardiologie et de Pneumologie de Quebec
馃嚚馃嚘Qu茅bec, Canada
Centro de Investigaci贸n del Maule SpA
馃嚚馃嚤Talca, Maule, Chile
CEC Centro de Estudios Cl铆nicos
馃嚚馃嚤Santiago, Metropolitana, Chile
Instituto Nacional del t贸rax
馃嚚馃嚤Santiago, Regi贸n Metropolitana, Chile
Fundaci贸n M茅dica San Cristobal
馃嚚馃嚤Santiago, Regi贸n Metropolitana, Chile
Centro Respiratorio Integral Limitada
馃嚚馃嚤Quillota, Valparaiso, Chile
Aarhus University Hospital - Department of Respiratory Diseases and Allergy, Research Unit
馃嚛馃嚢Aarhus N, Denmark
Gentofte Hospital - Lungemedicinsk forskningsafdeling
馃嚛馃嚢Hellerup, Denmark
Odense University Hospital - Department of Respiratory Medicine
馃嚛馃嚢Odense C, Denmark
Hopital Nord AP-HM (Assistance Publique H么pitaux De Marseille - Centre Hospitalier R茅gional de Marseille
馃嚝馃嚪Marseille, Bouches-du-Rh么ne, France
Hopital Larrey
馃嚝馃嚪Toulouse, Haute-Garonne, France
Barzilai Medical Center
馃嚠馃嚤Ashkelon, HaDarom, Israel
Hillel Yaffe Medical Center
馃嚠馃嚤Hadera, Haifa, Israel
Kaplan Medical Center
馃嚠馃嚤Rehovot, HaMerkaz, Israel
Shaare Zedek Medical Center
馃嚠馃嚤Jerusalem, Yerushalayim, Israel
Hadassah Medical Center - PPDS
馃嚠馃嚤Jerusalem, Yerushalayim, Israel
Azienda Ospedaliero Universitaria Di Modena Policlinico
馃嚠馃嚬Modena, Emilia-Romagna, Italy
A.O.U. Policlinico Vittorio Emanuele presidio "G.Rodolico"
馃嚠馃嚬Catania, Sicilia, Italy
Fondazione PTV Policlinico Tor Vergata
馃嚠馃嚬Roma, Italy
CHA Bundang Medical Center, CHA University
馃嚢馃嚪Seongnam-si, Gyeonggido, Korea, Republic of
Seoul National University Bundang Hospital
馃嚢馃嚪Seongnam-Si, Gyeonggido, Korea, Republic of
Gachon University Gil Medical Center
馃嚢馃嚪Incheon, Incheon Gwang'yeogsi, Korea, Republic of
The Catholic University of Korea - Eunpyeong St. Mary's Hospital
馃嚢馃嚪Seoul, Seoul Teugbyeolsi, Korea, Republic of
SMG - SNU Boramae Medical Center
馃嚢馃嚪Seoul, Seoul Teugbyeolsi, Korea, Republic of
Samsung Medical Center
馃嚢馃嚪Seoul, Korea, Republic of
Centro de Prevenci贸n y Rehabilitaci贸n de Enfermedades Pulmonares Cr贸nicas (CEPREP)
馃嚥馃嚱Monterrey, Nuevo Le贸n, Mexico
Unidad de Investigaci贸n Cl铆nica en Medicina, S.C.
馃嚥馃嚱Monterrey, Nuevo Le贸n, Mexico
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
馃嚥馃嚱Ciudad de Mexico, Mexico
Zuyderland Medisch Centrum - Heerlen
馃嚦馃嚤Heerlen, Limburg, Netherlands
Erasmus MC -Dr. Molewaterplein 40
馃嚦馃嚤Rotterdam, Zuid-Holland, Netherlands
Waikato Hospital
馃嚦馃嚳Hamilton, Waikato, New Zealand
Canterbury Respiratory Research Group
馃嚦馃嚳Christchurch, New Zealand
Clinica Ricardo Palma
馃嚨馃嚜Lima, Peru
Hospital Central de la Fuerza A茅rea del Per煤
馃嚨馃嚜Lima, Peru
Hospital Universitario Central de Asturias
馃嚜馃嚫Oviedo, Asturias, Spain
Hospital Universitario Son Espases
馃嚜馃嚫Palma de Mallorca, Baleares, Spain
Hospital Universitario de Bellvitge
馃嚜馃嚫L麓Hospitalet de LLobregat, Barcelona, Spain
Hospital Universitario Virgen de la Victoria
馃嚜馃嚫Malaga, M谩laga, Spain
Hospital Universitario Vall d'Hebron
馃嚜馃嚫Barcelona, Spain
Hospital Clinic de Barcelona
馃嚜馃嚫Barcelona, Spain
Hospital Universitario Virgen de Las Nieves
馃嚜馃嚫Granada, Spain
Hospital Universitario de La Princesa
馃嚜馃嚫Madrid, Spain
Far Eastern Memorial Hospital
馃嚚馃嚦New Taipei City, Taiwan
Taipei Veterans General Hospital
馃嚚馃嚦Taipei, Taiwan